Abstract
Although heart failure with preserved ejection fraction (HFpEF) is considered a disease of the elderly, younger patients are not spared from this syndrome. This study therefore investigated the associations among age, clinical characteristics, and outcomes in patients with HFpEF. Using data on patients with left ventricular ejection fraction ≥45% from 3 large HFpEF trials (TOPCAT [Aldosterone Antagonist Therapy for Adults With Heart Failure and Preserved Systolic Function], I-PRESERVE [Irbesartan in Heart Failure With Preserved Systolic Function], and CHARM Preserved [Candesartan Cilexetil in Heart Failure Assessment of Reduction in Mortality and Morbidity]), patients were categorized according to age: ≤55 years (n = 522), 56 to 64 years (n = 1,679), 65 to 74 years (n = 3,405), 75 to 84 years (n = 2,464), and ≥85 years (n = 398). This study compared clinical and echocardiographic characteristics, as well as mortality and hospitalization rates, mode of death, and quality of life across age categories. Younger patients (age ≤55 years) with HFpEF were more often obese, nonwhite men, whereas older patients with HFpEF were more often white women with a higher prevalence of atrial fibrillation, hypertension, and chronic kidney diseas...Continue Reading
Citations
Sep 24, 2019·Clinical Pharmacology and Therapeutics·Sophie Van Linthout, Carsten Tschöpe
Dec 5, 2019·European Heart Journal·Carolyn S P LamAdriaan A Voors
Jul 18, 2020·Acta Cardiologica·Sibille LejeuneAnne-Catherine Pouleur
Oct 28, 2019·European Heart Journal·Arnold C T Ng, Jeroen J Bax
Jul 6, 2020·Current Hypertension Reports·Karnika AyinapudiSuzanne Oparil
Nov 3, 2020·Circulation·Jennifer E HoCarolyn S P Lam
Sep 18, 2020·Journal of Cardiovascular Medicine·Adrianne CasebeerThomas Evers
Jul 28, 2020·European Journal of Internal Medicine·Stefano FumagalliNiccolò Marchionni
Jan 14, 2021·Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation·A UijlA W Hoes
Nov 27, 2019·JACC. Basic to Translational Science·Sheldon H Gottlieb
Oct 31, 2020·Heart and Vessels·Masahiro KitamuraNobuhiro Okamoto
Feb 21, 2021·Cardiovascular Diabetology·Sibille LejeuneAnne-Catherine Pouleur
Feb 23, 2020·Journal of the American College of Cardiology·Valentin Fuster
Jan 14, 2020·JACC. Heart Failure·Jordana B CohenJulio A Chirinos
Feb 10, 2020·JACC. Heart Failure·Jasper TrompIziah E Sama
Feb 26, 2021·Cardiology Research and Practice·Ngoc-Thanh-Van NguyenHoa Ngoc Chau
Mar 12, 2021·Clinical Cardiology·Carolyn S P LamLei Qin
Mar 3, 2021·European Journal of Heart Failure·Rebecca J WoolleyAdriaan A Voors
Mar 25, 2021·BMJ : British Medical Journal·Jasper TrompJennifer E Ho
May 8, 2021·The Journal of Clinical Hypertension·Anping CaiYingqing Feng
May 9, 2021·Clinical Cardiology·Kensuke TakabayashiRyuji Nohara
May 31, 2021·Heart Failure Clinics·Andrea SalzanoAlberto M Marra
May 31, 2021·Heart Failure Clinics·Hidemi SorimachiBarry A Borlaug
Jun 8, 2021·Frontiers in Physiology·Emmanuel Eroume A Egom
Jun 15, 2021·Frontiers in Medicine·Simon LebekStefan Wagner
Feb 17, 2021·The Journal of Cardiovascular Nursing·Kavita RadhakrishnanLinda Park